IP Library › Assignment 067679/0635
Patent Assignment
Reel/Frame 067679/0635

Assignment of Assignor's Interest

Recorded: 2024-06-10 Pages: 62
Assignor
INHIBRX, INC.
Executed: 2024-05-28
Assignee
INHIBRX BIOSCIENCES, INC.
11025 N. TORREY PINES ROAD, SUITE 140, LA JOLLA, CALIFORNIA, 92037
Covered Properties (46)
Polypeptides Comprising Modified IL-2 Polypeptides and Uses Thereof
Application: 63/047,681 →
NKp46-Binding Polypeptides and Uses Thereof
Application: 18/685,665 →
Publication: US 2025/0136681
NKP46-Binding Polypeptides and Uses Thereof
Application: 63/238,429 →
NKp46-Targeted Modified IL-2 Polypeptides and Uses Thereof
Application: 18/685,666 →
Publication: US 2024/0376198
NKP46-Targeted Modified IL-2 Polypeptides and Uses Thereof
Application: 63/238,431 →
NKP46-Targeted Modified IL-2 Polypeptides and Uses Thereof
Application: 63/296,776 →
Multivalent and Multispecific OX40-Binding Fusion Proteins
Application: 15/404,167 →
Publication: US 2017/0198051
Multivalent and Multispecific OX40-Binding Fusion Proteins
Application: 16/295,332 →
Publication: US 2019/0263916
Multivalent and Multispecific OX40-Binding Fusion Proteins
Application: 17/398,851 →
Publication: US 2022/0106397
Multivalent and Multispecific OX40-Binding Fusion Proteins
Application: 62/277,027 →
OX40-Binding Polypeptides and Uses Thereof
Application: 16/538,216 →
Publication: US 2020/0055946
OX40-Binding Polypeptides and Uses Thereof
Application: 17/818,106 →
Publication: US 2023/0128188
OX40-Binding Polypeptides and Uses Thereof
Application: 18/658,421 →
Publication: US 2024/0409651
OX40-Binding Polypeptides and Uses Thereof
Application: 62/718,106 →
Pd-1 Single Domain Antibodies and Therapeutic Compositions Thereof
Application: 16/600,298 →
Publication: US 2020/0190193
Pd-1 Single Domain Antibodies and Therapeutic Compositions Thereof
Application: 17/524,016 →
Publication: US 2022/0162316
PD-1 Single Domain Antibodies and Therapeutic Compositions Thereof
Application: 18/589,536 →
Publication: US 2024/0317860
Pd-1 Single Domain Antibodies and Therapeutic Compositions Thereof
Application: 62/744,615 →
Pd-1 Single Domain Antibodies and Therapeutic Compositions Thereof
Application: 62/791,152 →
Type Iii Secretion System Targeting Molecules
Application: 15/144,470 →
Publication: US 2016/0318996
Type III Secretion System Targeting Molecules
Application: 16/419,677 →
Publication: US 2019/0345235
Type Iii Secretion System Targeting Molecules
Application: 62/155,967 →
Type Iii Secretion System Targeting Molecules
Application: 62/254,992 →
Gamma Delta T-Cell-Binding Polypeptides and Uses Thereof
Application: 63/296,774 →
Gamma Delta T-Cell-Binding Polypeptides and Uses Thereof
Application: 63/417,926 →
Gamma Delta T-Cell-Targeted Modified Il-2 Polypeptides and Uses Thereof
Application: 63/296,770 →
Gamma Delta T-Cell-Targeted Modified Il-2 Polypeptides and Uses Thereof
Application: 63/417,910 →
5T4 Single Domain Antibodies and Therapeutic Compositions Thereof
Application: 17/283,830 →
Publication: US 2021/0340273
5T4 Single Domain Antibodies and Therapeutic Compositions Thereof
Application: 62/744,631 →
5T4 Single Domain Antibodies and Therapeutic Compositions Thereof
Application: 62/877,824 →
B7H3 Single Domain Antibodies and Therapeutic Compositions Thereof
Application: 17/283,902 →
Publication: US 2023/0124851
B7H3 Single Domain Antibodies and Therapeutic Compositions Thereof
Application: 62/744,640 →
B7H3 Single Domain Antibodies and Therapeutic Compositions Thereof
Application: 62/832,274 →
B7H3 Single Domain Antibodies and Therapeutic Compositions Thereof
Application: 62/877,812 →
CD28 Single Domain Antibodies and Multivalent and Multispecific Constructs Thereof
Application: 17/795,500 →
Publication: US 2023/0348600
CD28 Single Domain Antibodies and Multivalent and Multispecific Constructs Thereof
Application: 62/967,533 →
Multispecific Polypeptide Constructs Having Constrained CD3 Binding and Methods of Using the Same
Application: 15/951,137 →
Publication: US 2019/0010242
Multispecific Polypeptide Constructs Having Constrained CD3 Binding and Methods of Using the Same
Application: 18/520,308 →
Publication: US 2024/0101704
Multispecific Polypeptides Having Dual Effector Function and Methods of Using the Same
Application: 62/484,217 →
Multispecific Polypeptide Constructs Having Constrained CD3 Binding and Related Methods and Uses
Application: 16/380,963 →
Publication: US 2019/0330366
Multispecific Polypeptide Constructs Having Constrained CD3 Binding and Related Methods and Uses
Application: 18/206,354 →
Publication: US 2023/0295336
Multispecific Polypeptide Constructs Having Constrained CD3 Binding and Related Methods and Uses
Application: 62/656,331 →
Multispecific Polypeptide Constructs Containing a Constrained CD3 Binding Domain and a Receptor Binding Region and Methods of Using the Same
Application: 16/520,293 →
Publication: US 2020/0048350
Multispecific Polypeptide Constructs Containing a Constrained CD3 Binding Domain and a Co-Stimulatory Receptor Binding Region and Methods of Using the Same
Application: 62/702,888 →
Multispecific Polypeptide Constructs Containing a Constrained CD3 Binding Domain and a Co-Stimulatory Receptor Binding Region and Methods of Using the Same
Application: 62/744,641 →
Multispecific Polypeptide Constructs Containing a Constrained CD3 Binding Domain and a Receptor Binding Region and Methods of Using the Same
Application: 62/832,268 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 4, 2015
From: HOLLANDS, ANDREW; TIMMER, JOHN C.; DEVERAUX, QUINN; ECKELMAN, BRENDAN P.
To: INHIBRX LP
Reel/Frame 037215/0029 →
Assignment of Assignor's Interest Apr 14, 2016
From: ECKELMAN, BRENDAN P.; TIMMER, JOHN C.; HATA, CHELSIE; JONES, KYLE S.
To: INHIBRX LP
Reel/Frame 038281/0946 →
Assignment of Assignor's Interest Apr 14, 2016
From: HOLLANDS, ANDREW; TIMMER, JOHN C.; DEVERAUX, QUINN; ECKELMAN, BRENDAN P.
To: INHIBRX LP
Reel/Frame 038281/0890 →
Assignment of Assignor's Interest Aug 17, 2017
From: ECKELMAN, BRENDAN P.; TIMMER, JOHN C.; HATA, CHELSIE; JONES, KYLE S.
To: INHIBRX LP
Reel/Frame 043582/0908 →
Merger and Change of Name May 22, 2018
From: INHIBRX LP; TENIUM THERAPEUTICS, INC.
To: INHIBRX, INC.
Reel/Frame 046215/0084 →
Assignment of Assignor's Interest Nov 9, 2018
From: TIMMER, JOHN C.; KAPLAN, MIKE D.; WILLIS, KATELYN M.; PANDIT, RAYJAY A.
To: INHIBRX, INC.
Reel/Frame 047825/0940 →
Assignment of Assignor's Interest Jan 23, 2019
From: TIMMER, JOHN C.; KAPLAN, MIKE D.; WILLIS, KATELYN M.; PANDIT, RAJAY A.
To: INHIBRX, INC.
Reel/Frame 048106/0123 →
Assignment of Assignor's Interest Jul 10, 2019
From: TIMMER, JOHN C.; CRAGO, WILLIAM; JONES, KYLE; WILLIS, KATELYN
To: INHIBRX, INC.
Reel/Frame 049711/0470 →
Assignment of Assignor's Interest Sep 4, 2019
From: RASCON, LUCAS
To: INHIBRX, INC.
Reel/Frame 050265/0685 →
Assignment of Assignor's Interest Oct 18, 2019
From: TIMMER, JOHN C.; KAPLAN, MIKE D.; WILLIS, KATELYN M.; PANDIT, RAJAY A.
To: INHIBRX, INC.
Reel/Frame 050758/0478 →
Assignment of Assignor's Interest Mar 16, 2020
From: PANDIT, RAJAY A.; TIMMER, JOHN C.; SANABRIA, ANGELICA N.; SULZMAIER, FLORIAN
To: INHIBRX, INC.
Reel/Frame 052121/0250 →
Assignment of Assignor's Interest Jun 14, 2021
From: TIMMER, JOHN C.; SULZMAIER, FLORIAN; WILLIS, KATELYN M.; BECKLUND, BRYAN
To: INHIBRX, INC.
Reel/Frame 056531/0384 →
Assignment of Assignor's Interest Nov 16, 2021
From: PANDIT, RAJAY A.; TIMMER, JOHN C.; SANABRIA, ANGELICA N.; SULZMAIER, FLORIAN
To: INHIBRX, INC.
Reel/Frame 058121/0619 →
Intellectual Property Security Agreement Feb 28, 2022
From: INHIBRX, INC.
To: OXFORD FINANCE LLC
Reel/Frame 059262/0780 →
Assignment of Assignor's Interest Jul 13, 2022
From: TIMMER, JOHN C.; ECKELMAN, BRENDAN P.; PANDIT, RAJAY A.; CRAGO, WILLIAM
To: INHIBRX, INC.
Reel/Frame 060492/0877 →
Assignment of Assignor's Interest Jul 13, 2022
From: BECKLUND, BRYAN; JONES, KYLE S.; ROBINSON, KAITLYN N.; ECKLES, ANDREW M.
To: INHIBRX, INC.
Reel/Frame 060492/0856 →
Assignment of Assignor's Interest Jul 13, 2022
From: TIMMER, JOHN C.; ECKELMAN, BRENDAN P.; PANDIT, RAJAY A.; CRAGO, WILLIAM
To: INHIBRX, INC.
Reel/Frame 060492/0836 →
Assignment of Assignor's Interest Jul 13, 2022
From: BECKLUND, BRYAN; JONES, KYLE S.; ROBINSON, KAITLYN N.; ECKLES, ANDREW M.
To: INHIBRX, INC.
Reel/Frame 060492/0886 →
Assignment of Assignor's Interest Dec 6, 2022
From: BECKLUND, BRYAN R.; JONES, KYLE S.; ROBINSON, KAITLYN N.; ECKLES, ANDREW M.
To: INHIBRX, INC.
Reel/Frame 061988/0311 →
Assignment of Assignor's Interest Dec 6, 2022
From: BECKLUND, BRYAN R.; JONES, KYLE S.; ROBINSON, KAITLYN N.; ECKLES, ANDREW M.
To: INHIBRX, INC.
Reel/Frame 061988/0330 →
Assignment of Assignor's Interest Mar 15, 2024
From: TIMMER, JOHN C.; ECKELMAN, BRENDAN P.; PANDIT, RAJAY A.; CRAGO, WILLIAM
To: INHIBRX, INC.
Reel/Frame 066781/0220 →
Assignment of Assignor's Interest Mar 15, 2024
From: TIMMER, JOHN C.; ECKELMAN, BRENDAN P.; PANDIT, RAJAY A.; CRAGO, WILLIAM
To: INHIBRX, INC.
Reel/Frame 066781/0177 →
Assignment of Assignor's Interest Mar 19, 2024
From: PANDIT, RAJAY A.; TIMMER, JOHN C.; SANABRIA, ANGELICA N.; SULZMAIER, FLORIAN
To: INHIBRX, INC.
Reel/Frame 066819/0469 →
Release of Security Interest Jun 3, 2024
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT
To: INHIBRX, INC.
Reel/Frame 067606/0247 →
Assignment of Assignor's Interest Jun 6, 2024
From: TIMMER, JOHN C.; CRAGO, WILLIAM; JONES, KYLE; WILLIS, KATELYN
To: INHIBRX, INC.
Reel/Frame 067643/0315 →